UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis

The Journal of pharmacology and experimental therapeutics, 2012-02, Vol.340 (2), p.350

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-( N, N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2179-2185

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory effect of carboxylic acid group on hERG binding

Bioorganic & medicinal chemistry letters, 2006-11, Vol.16 (21), p.5507-5512

2006

Link zum Volltext

Verfügbarkeit prüfen

[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase

Molecular imaging and biology, 2022-10, Vol.24 (5), p.830-841

2022

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2003-02, Vol.13 (3), p.561-566

2003

Link zum Volltext

Verfügbarkeit prüfen

Anthranilamide-based N, N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2186-2189

2009

Link zum Volltext

Verfügbarkeit prüfen

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 3: Design, synthesis and sar of orally bioavailable benzamidine-P4 inhibitors

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1229-1234

2004

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Linear and Angular Triquinane Skeletons by O-Stannyl Ketyl-Promoted Fragmentation−Cyclization Reactions of α-Keto Cyclopropanes

Journal of organic chemistry, 1997-01, Vol.62 (1), p.174-181

1997

Link zum Volltext

Verfügbarkeit prüfen

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 2: A survey of P4 motifs

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1221-1227

2004

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.983-987

2004

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.989-993

2004

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P1 Structure-activity relationships of the substituted 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides

Bioorganic & medicinal chemistry letters, , Vol.12 (12), p.1651-1655

Link zum Volltext

Verfügbarkeit prüfen

N, N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (9), p.2073-2078

2004

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors

Arteriosclerosis, thrombosis, and vascular biology, 2003-06, Vol.23 (6), p.1098

2003

Link zum Volltext

Verfügbarkeit prüfen

One- and Two-Electron Reactions from the Rearrangement of α-Ketocyclopropanes by O-Stannyl Ketyls

Journal of organic chemistry, 1997-12, Vol.62 (26), p.9159-9164

1997

Link zum Volltext

Verfügbarkeit prüfen

Tetrachlorophthalimido- and Pent-4-enoyl-Protected Glucosamines as Precursors for Preparation of 2-Azido-2-deoxyglucopyranosyl Building Blocks

Journal of organic chemistry, 1998-05, Vol.63 (11), p.3790-3792

1998

Link zum Volltext

Verfügbarkeit prüfen

Reactions of Tin(IV) Enolates and Radicals Derived from the Tin Hydride Scission of Cyclopropyl Ketones

Journal of organic chemistry, 1997-08, Vol.62 (16), p.5248-5249

1997

Link zum Volltext

Verfügbarkeit prüfen

1-(2-Naphthyl)-1 H -pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (5), p.1229-1234

2004

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and SAR of Amino Acid Derivatives as Factor Xa Inhibitors

Bioorganic & medicinal chemistry letters, 2001-11, Vol.11 (22), p.2947-2950

2001

Link zum Volltext

Verfügbarkeit prüfen

The Mitsunobu Reaction of Tetrachlorophthalimide

Synlett, 1999-05, Vol.1999 (5), p.565-566

1999

Link zum Volltext

Verfügbarkeit prüfen

Construction of a linear triquinane skeleton by an O-stannyl ketyl radical rearrangement

Chemical communications (Cambridge, England), 1996 (13), p.1567

1996

Link zum Volltext

Verfügbarkeit prüfen

Fragmentation-cyclization reactions of O-stannyl ketyls: The synthesis of an angular triquinane skeleton

Tetrahedron letters, 1996-02, Vol.37 (8), p.1177-1178

1996

Link zum Volltext

Verfügbarkeit prüfen

Specific Inhibition of Syk Suppresses Leukocyte Immune Function and Alleviates Inflammation In Rodent Models of Rheumatoid Arthritis

Blood, 2010-11, Vol.116 (21), p.1727-1727

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Syk Activity Is Sufficient for Inhibitory Effect in Animal Models of Autoimmune Diseases

Blood, 2008-11, Vol.112 (11), p.680-680

2008

Link zum Volltext

Verfügbarkeit prüfen

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido )-5-metho xybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2179-2185

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Physical Sciences
(21)
Chemistry
(20)
Chemistry, Organic
(19)
Life Sciences & Biomedicine
(17)
Biological And Medical Sciences
(13)
Factor Xa Inhibitors
(13)
Medical Sciences
(13)
Animals
(12)
Pharmacology & Pharmacy
(12)
Pharmacology. Drug Treatments
(12)
Blood. Blood Coagulation. Reticuloendothelial System
(11)
Chemistry, Medicinal
(11)
Structure-Activity Relationship
(10)
Humans
(9)
Rats
(9)
Drug Design
(7)
Biological Availability
(6)
Molecular Medicine
(6)
Organic Chemistry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-( N, N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Inhibitory effect of carboxylic acid group on hERG binding

[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase

Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors

Anthranilamide-based N, N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 3: Design, synthesis and sar of orally bioavailable benzamidine-P4 inhibitors

Synthesis of Linear and Angular Triquinane Skeletons by O-Stannyl Ketyl-Promoted Fragmentation−Cyclization Reactions of α-Keto Cyclopropanes

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor xa inhibitors. Part 2: A survey of P4 motifs

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs

Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity

Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P1 Structure-activity relationships of the substituted 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides

N, N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors

Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors

One- and Two-Electron Reactions from the Rearrangement of α-Ketocyclopropanes by O-Stannyl Ketyls

Tetrachlorophthalimido- and Pent-4-enoyl-Protected Glucosamines as Precursors for Preparation of 2-Azido-2-deoxyglucopyranosyl Building Blocks

Reactions of Tin(IV) Enolates and Radicals Derived from the Tin Hydride Scission of Cyclopropyl Ketones

1-(2-Naphthyl)-1 H -pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

Design, Synthesis, and SAR of Amino Acid Derivatives as Factor Xa Inhibitors

The Mitsunobu Reaction of Tetrachlorophthalimide

Construction of a linear triquinane skeleton by an O-stannyl ketyl radical rearrangement

Fragmentation-cyclization reactions of O-stannyl ketyls: The synthesis of an angular triquinane skeleton

Specific Inhibition of Syk Suppresses Leukocyte Immune Function and Alleviates Inflammation In Rodent Models of Rheumatoid Arthritis

Inhibition of Syk Activity Is Sufficient for Inhibitory Effect in Animal Models of Autoimmune Diseases

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido )-5-metho xybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Suchergebnisse filtern